Somatostatin analogs (e.g., octreotide, lanreotide) will continue to be main therapies for functioning neuroendocrine tumors over the next years. Pasireotide, a new panreceptor analog, might ...

Overexpression of peritumoral vascular somatostatin receptors with high affinity for SSTR2-binding analogs, such as octreotide, has been reported in several human tumors (neuroendocrine tumors ...

She initially received a long-acting somatostatin analog (octreotide ... had been diagnosed as having metastatic pulmonary neuroendocrine tumor. The patient's medical and family history was ...

long-acting subcutaneous depot of octreotide under development for the treatment of three chronic and severe disease indications: acromegaly, gastroenteropancreatic neuroendocrine tumors (GEP-NET ...

NET are heterogeneous tumors that arise from the neuroendocrine cells of the digestive tract and other organs, such as the lung and pancreas. Most patients with advanced disease face a poor prognosis.

In-111-DTPA-octreotide scan (A) demonstrates recurrent mesenteric nodule (arrow) on the anterior view in a patient with a mid-gut carcinoid tumor resected 5 years previously, with no other tumor ...

NET: Neuroendocrine tumor. Data from [20,94 ... Somatostatin analogs (e.g., octreotide, lanreotide) will continue to be main therapies for functioning neuroendocrine tumors over the next years.

Camurus (NASDAQ STO: CAMX) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) ...